SUMMARY
INTRODUCTION
Sleep apnea syndrome (SAS) is a disorder with an increasing prevalence and well-established neurocognitive dysfunction and cardiovascular sequelae (1, 2) . Although debate is ongoing, Young et al. reported that the prevalence of SAS was 3-28% (3, 4) . Older patients and African-Americans are more prone to the disorder (5).
Several tests and questionnaires can be used for the diagnosis of the SAS, but the gold standard remains nocturnal polysomnography (nPSG). The main problem with PSG is accessibility, because PSG is not available at every medical center and requires experienced technicians and physicians. Flemons et al. reported that non-emergency patients may have to wait 14 (7-60) months for PSG in England (6) . Similarly, the waiting time for the test at our center is 14 months, which delays diagnosis and treatment.
Excessive daytime sleepiness (EDS) is a frequent symptom of SAS patients. It may affect jobs requiring attention and may cause reduced productivity, motor vehicle accidents, industrial accidents, or workrelated injuries generally (7) . Previous studies have shown that patients with EDS may sleep during the daytime and are suitable for short periods of PSG evaluation (8, 9) . However, the validity, role, and appropriate techniques fordaytime PSG (dPSG) in the diagnosis and management of SAS are unclear.
The aim of the study was to assess the role of daytime PSG in the diagnosis and evaluation of SAS, and the correlation between nPSG and dPSG.
PATIENTS and METHOD

Patients
We recruited consecutive patients referred to our laboratory with complaints of snoring and EDS over a 12-month period. Eighty subjects were invited to participate in the study; 20 refused to participate. Sixty subjects who were willing to participate were invited to the sleep laboratory and evaluated for exclusion criteria by a sleep physician. Twelve subjects were excluded, leaving 48 who participated in the study. The inclusion and exclusion criteria are presented in Table 1 .
Local Ethics Committee approval was obtained. Written informed consent was provided by all subjects.
Study Design
We conducted a prospective, cross-over study at the sleep laboratory of a university hospital over a 12-month period. Demographic characteristics, body mass indices (BMI), neck circumference, Epworth sleepiness scale (ESS), co-morbidities, and alcohol, drug, and smoking histories were recorded before the study. All subjects planned to undergo both 7-hours nPSG and 7-hours dPSG and were randomized into two groups: the first had nPSG before dPSG, while the other group had dPSG before nPSG (Figure 1 ). Patients were warned to not be sleep-deprived before the PSG sessions. The time interval between the two PSGs was 48-72 h. nPSG was performed from 00:00-07:00 hours and dPSG from 10:00-17:00 hours.
Polysomnography
A Compumedics E-series with Profusion software was the standard PSG machine. All measurements and assessments were performed according to the AASM 2007 guidelines (10) . Pulse oximetry, C3-A2, C4-A1, O1-A2, and O2-A1 electroencephalograms, electrooculograms, electromyograms (mentalis and legs), and electrocardiograms were recorded, and respiration was monitored using a nasal cannula, oronasal thermistor, and thoracoabdominal piezo sensors in dPSG and nPSG. Polysomnography was performed with strict control of the environment.
Only the technician was present in the laboratory during PSG. Cleaning of the laboratory was performed outside of study hours. All cell phones and other electronic devices were switched off. The temperature was fixed at 22-24°C by means of air conditioning. Daylight was eliminated using thick, dark curtains.
Scoring
Polysomnography data were scored and analyzed by two experienced and blinded sleep physicians. Sleep stages and events were scored according to the AASM 2007 guidelines (10) . Apnea was defined as cessation of airflow for ≥ 10 s, and hypopnea was defined as a > 50% reduction in airflow accompanied by oxygen desaturation of ≥ 3% for ≥ 10 s. The respiratory disturbance index (RDI) was defined as the average number of episodes of apnea, hypopnea, and respiratory event-related arousal per hour of sleep. Sleep stages, sleep efficiency, total sleep time (TST), RDI, oxygen desaturation index (ODI), lowest oxygen saturation (SpO 2 ), and time period of oxygen saturation < 90% (SpO 2 < 90%) were analyzed. Individuals with an RDI ≥ 5 were considered to have SAS, which was classified as mild (RDI 5-15), moderate (RDI 16-30), or severe (RDI ≥ 30). Obesity hypoventilation syndrome (OHS) was defined as BMI ≥ 30 kg/m 2 , chronic daytime hypercapnia (PaCO 2 < 45 mmHg), and RDI ≥ 5/h in the absence of other known causes of hypercapnia (11) .
Statistical Analysis
Demographic characteristics, BMI, neck circumferences, PSG parameters and results, ESS scores, and co-morbidities were analyzed using Wilcoxon signed-rank tests, paired t-tests, Spearman's rho and the Mann-Whitney U-test with the IBM SPSS software (ver. 20).
RESULTS
In total, 48 subjects were included in the study. Six subjects did not participate in nPSG or dPSG PSG and one subject did not have sufficient sleep time at the PSG sessions. These seven subjects were excluded; therefore, data for 41 subjects (30 males, 11 females) were analyzed (Figure 1 Table 2 . The mean ESS score was 11.3 ± 5.94. There was no correlation between ESS score and symptoms (p< 0.05) but not with comorbidities (p> 0.05). Twenty one patients were current or former smokers, but there were no correlations between smoking and sleep parameters, BMI, or neck circumference (p> 0.05).
Sleep stages in nPSG and dPSG were similar, with the exception of stage 3. The stage 3 sleep ratio was higher in nPSG than dPSG (dPSG: 13.5 ± 9.9% vs. nPSG: 19 ± 10.8%; this difference was statistically significant, p= 0.01). RDI, ODI, minimum saturation, TST, and the time period of SpO 2 < 90%, did not differ significantly between dPSG and nPSG. Although the duration of SpO 2 < 90% was longer in nPSG than dPSG (41.0 ± 70.8 vs. 29.4 ± 65.4), the difference was not statistically significant (p= 0.17). Sleep efficiencies in nPSG and dPSG were 86% ± 9.7 and 80% ± 13.8, respectively (mean ± SD).This difference was statistically significant (p= 0.034), but there was Table 4) .
DISCUSSION
In this study, we showed that dPSG is an effective method for diagnosing SAS and that the difference between dPSG and nPSG parameters was not statistically significant. RDI, ODI, minimum saturation, and duration of saturation < 90% did not differ between nPSG and dPSG (p> 0.05).
Polysomnography during the daytime was used previously in various ways. Goode and Slyter examined 310 patients, diagnosed 102 cases of obstructive sleep apnea syndrome (OSAS) using dPSG, and reported dPSG to be a useful test (12 (13, 14) . In this study, we did not perform sleep deprivation before either PSG session; however, we cannot eliminate the possibility of intentional sleep deprivation by patients to achieve better test results.
Some studies of the value of daytime PSG assessed less than 2h of sleep and reported that dPSG was not useful without nPSG (15) (16) (17) . However, these studies did not include sufficient sleep time to evaluate Yoshiko and Okada reported dPSG to be a useful screening test with significant false negativity (18) . Van Keimpema reported 88% specificity and 66% sensitivity (17) . However, Miyata et al. reported greater specificity (100%) and sensitivity (81%), likely due to increased TST (19) . In our study, we performed 7-h dPSG and nPSG. All subjects were diagnosed with SAS by both dPSG and nPSG, probably because only patients with EDS were included in the study. However, excluding patients due to lack of participation or inadequate sleep time may have affected the results.
Sleep efficiency depends primarily on the patient and environment. Le Bon et al. reported a first-night effect of 15-25% in sleep studies, which could lead to misdiagnoses (20) . This first-night effect may be related to both patients' habits (bed, pillow, room change) and discomfort due to the PSG equipment. However, sleep efficiency in our study was high (nPSG: 86 ± 9.7% and dPSG: 80 ± 13.8%), likely due to our strict environmental controlsfor provision of sleep hygiene. Most patients admitted to sleep laboratories are overweight or obese. Al-Jawder et al. reported a 33.1% OHS frequency in a daytime PSG study (21) . However, only four patients had OHS in our study, which might have been due to our relatively less obese population. It is known that as BMI increases, RDI increases; however, neck circumference is a better predictor and correlatesbetter with the severity of sleep apnea than BMI (22) (23) (24) . Although our subjects had neck circumferences lower than the upper limits, neck circumference was correlated with RDI and ODI in nPSG and dPSG (p< 0.05), but BMI was not (p> 0.05) ( Table 2 ). This finding is consistent with previous reports.
The Epworth sleepiness scale assesses the effects of sleep problems on daily life. Patients were categorized as sleepy or non-sleepy according to their ESS scores (25, 26) . In our study, ESS did correlate with symptoms (p< 0.05) but did not correlate with comorbidities, SAS severity, lowest saturation, duration of SpO 2 < 90%, sleep stage, or PSG efficiency (p> 0.05). This was likely due to the subjective nature of the test, because the education level of the subjects and characteristics of the population may affect the overall scores.
The average waiting time for PSG in Turkey is nearly 1 year (7-12 months). This can lead to patients contacting multiple sleep laboratories in an attempt to undergo PSG at an earlier date. However, multiple admissions may cause unreal laboratory load. Unfortunately, the current social security system in Turkey does not prevent multiple admissions. However, performing dPSG may increase the laboratory capacity, efficiency, and shorten waiting lists.
Although dPSG is simple to perform, the sleep technicians must be careful to control the environment. Another problem with the dPSG is the possibility of affecting the life style of the subjects due to having many hours at the laboratory during daytime (i.e having lunch).
There were several limitations to this study. First, although we recruited referred patients consecutively and did not perform any gender selection, a greater number of male subjects were included. This was probably due to the male preponderance of SAS (3). Second, our study population comprised relatively young subjects, which might explain the scarcity of comorbidities as these increase with advancing age. Third, information regarding the sleep habits and occupations of the subjects was lacking. Occupation can affect sleep habits. People who work night shifts (night watchman, taxi drivers) may normally sleep during the day. These sleep habits may decrease the efficiency of nPSG and exaggerate the efficiency of dPSG. Fourth, a small number of subjects were included, which this was due to the strict exclusion criteria. Although we have started with 80 participants, 39 were eliminated based on the exclusion criteria, insufficient sleep time, or unwillingness to participate. Also, the study concerned only patients with EDS; therefore, the results cannot be generalized to all sleep apnea patients.
CONCLUSION
Daytime PSG, when performedappropriately (patient selection and environment control), is an effective tool for diagnosing sleep disorders in patients with EDS. dPSG may increase the capacity of sleep laboratories and decrease the amount of times that patientsmust waitto undergo PSG.
